Related references
Note: Only part of the references are listed.Piperacillin penetration into tissue of critically ill patients with sepsis-Bolus versus continuous administration?
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
Pharmacokinetic variability of extended interval tobramycin in burn patients
David Bracco et al.
BURNS (2008)
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
Nikolaos Markou et al.
CLINICAL THERAPEUTICS (2008)
Antibiotic resistance - What's dosing got to do with it?
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2008)
A novel way to investigate the effects of plasma exchange on antibiotic levels: use of microdialysis
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Peggy S. McKinnon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India
A. Nusrath Unissa et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Optimizing use of colistin and polymyxin B in the critically ill
Roger L. Nation et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Replacement of 24-h creatinine clearance by 2-h creatinine clearance in intensive care unit patients:: a single-center study
Manuel E. Herrera-Gutierrez et al.
INTENSIVE CARE MEDICINE (2007)
A population pharmacokinetic approach to ceftazidime use in burn patients: influence of glomerular filtration, gender and mechanical ventilation
Jean Marie Conil et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Piperacillin-tazobactam for Pseudomonas aeruginosa infection:: Clinical implications of an extended-infusion dosing strategy
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2007)
Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units
Juliana F. Roos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Population pharmacokinetic parameters of vancomycin in critically ill patients
P. Llopis-Salvia et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients
Chonghua Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis
Cornelia Buerger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury
Tyree H. Kiser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae
SK Henderson-Begg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli
L Lorente et al.
ANNALS OF PHARMACOTHERAPY (2006)
The pharmacokinetic and pharmacodynamic properties of vancomycin
MJ Rybak
CLINICAL INFECTIOUS DISEASES (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli
SK Olofsson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy
RL Trotman et al.
CLINICAL INFECTIOUS DISEASES (2005)
Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides
J Rello et al.
CRITICAL CARE MEDICINE (2005)
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
The pharmacokinetic and pharmacodynamic profile of tigecycline
AK Meagher et al.
CLINICAL INFECTIOUS DISEASES (2005)
Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia
E Boselli et al.
CRITICAL CARE MEDICINE (2005)
12-hour versus 24-hour creatinine clearance in critically ill pediatric patients
S Pong et al.
PEDIATRIC RESEARCH (2005)
Pharmacokinetic/pharmacodynamic profile for tigecycline - a new glycylcycline antimicrobial agent
AK Meagher et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
The international sepsis forum consensus conference on definitions of infection in the intensive care unit
T Calandra et al.
CRITICAL CARE MEDICINE (2005)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection
S Jaruratanasirikul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Assessment of renal function in recently admitted critically ill patients with normal serum creatinine
EAJ Hoste et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
The haemodynamic and metabolic effects of epinephrine in experimental hyperdynamic septic shock
D Di Giantomasso et al.
INTENSIVE CARE MEDICINE (2005)
Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients
R Sauermann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis
A Novelli et al.
CLINICAL PHARMACOKINETICS (2005)
Pharmacokinetic/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics - The minimum inhibitory concentration versus stationary concentration
JW Mouton et al.
CLINICAL PHARMACOKINETICS (2005)
Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects
G Muralidharan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation
BM Lomaestro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Use of antibacterial agents in renal failure
LL Livornese et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2004)
Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity
KM Olsen et al.
CRITICAL CARE MEDICINE (2004)
Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling
T Gumbo et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia
E Boselli et al.
INTENSIVE CARE MEDICINE (2004)
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis
J Garnacho-Montero et al.
CRITICAL CARE MEDICINE (2003)
Cefepime versus cefpirome: The importance of creatinine clearance
J Lipman et al.
ANESTHESIA AND ANALGESIA (2003)
Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis
D Di Giantomasso et al.
INTENSIVE CARE MEDICINE (2003)
Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors
A Barbot et al.
INTENSIVE CARE MEDICINE (2003)
Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid
WA Craig
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Pharmacokinetics of linezolid in subjects with renal dysfunction
ME Brier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections
AP MacGowan
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Safety and tolerability of linezolid
G French
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Bacteremic sepsis in intensive care:: Temporal trends in incidence, organ dysfunction, and prognosis
S Hugonnet et al.
CRITICAL CARE MEDICINE (2003)
Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
S Harbarth et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia
F Pea et al.
CLINICAL PHARMACOKINETICS (2003)
Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia
S Jaruratanasirikul et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Norepinephrine and vital organ blood flow
D Di Giantomasso et al.
INTENSIVE CARE MEDICINE (2002)
In vivo pharmacodynamics of a new oxazolidinone (linezolid)
D Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit
JA Rebuck et al.
PHARMACOTHERAPY (2002)
Experience with a once-daily dosing program of aminoglycosides in critically ill patients
SE Buijk et al.
INTENSIVE CARE MEDICINE (2002)
Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam when administered by continuous infusion and intermittent dosing
DS Burgess et al.
CLINICAL THERAPEUTICS (2002)
Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia
MJ Gentry-Nielsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?
J Lipman et al.
INTENSIVE CARE MEDICINE (2002)
Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients
R Kitzes-Cohen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections
SLCE Buijk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: Prospective multicenter randomized study
M Wysocki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Use of antibacterial agents in renal failure
LL Livornese et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2001)
Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome
JC Marshall
CRITICAL CARE MEDICINE (2001)
The pharmacokinetics of colistin in patients with cystic fibrosis
MD Reed et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients
GM Joynt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing
J Lipman et al.
INTENSIVE CARE MEDICINE (2001)
Impaired target site penetration of β-lactams may account for therapeutic failure in patients with septic shock
C Joukhadar et al.
CRITICAL CARE MEDICINE (2001)
Selection of antibiotic-resistant bacterial mutants: Allelic diversity among fluoroquinolone-resistant mutations
JF Zhou et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimens
A MacGowan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Intermittent and continuous ceftazidime infusion for critically ill trauma patients
SD Hanes et al.
AMERICAN JOURNAL OF SURGERY (2000)
Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa
RP Smith et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection
JD Knudsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures
F Pea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa
JM Hyatt et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2000)
Share Paper
